[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: In Press ::
Back to the articles list Back to browse issues page
Insomnia drug therapy in COVID-19 patients; a Letter to Editor
Ali Rismanbaf
Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran , alirismanbaf74@gmail.com
Abstract:   (71 Views)
Dear Editor,
Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by the newly emerging SARS-CoV-2 virus that was first reported in December 2019 and was announced as a pandemic disease on March 11th, according to a World Health Organization (WHO) warning (1). SARS-CoV-2 is mainly transmitted through respiratory droplets and close contact, accordingly, requires treatment in isolation. It has been reported that many patients developed sleep disturbances due to isolation treatment or medication use, which can lead to pathological events and impaired immunity, and need to prescribe hypnotic medications (2). Also, some patients may have taken hypnotic medications before developing COVID-19 and may be dependent on these medications, and now, with the onset of COVID-19 and the addition of new drugs for its treatment, they need to change their hypnotic medications.
Keywords: Coronavirus, Sleep disorder, Hypnotics and Sedatives, Drug therapy
     
Type of Study: Letter to Editor | Subject: psychiatry
Received: 2020/03/21 | Published: 2017/07/15
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print



Back to the articles list Back to browse issues page
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.05 seconds with 32 queries by YEKTAWEB 4139